ANIK Anika Therapeutics Inc. - Common Stock
NASDAQ · Biotechnology · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Jul 29, 2026
$19,10
· % da faixa de 52 semanas
· acima do mínimo
· para alta
$8,67mínima 52 sem
$22,88máxima 52 sem
Capitalização de Mercado (MRQ)
$256M
P/E (TTM)
-70.7
EPS (TTM)
$-0.27
Receita (TTM)
$121M
seus distintivos
Intervalo 52 Semanas
$9–$23
Classificação do Analista
BUY
Preço-Alvo
$22
P/E
-70.7
ROE
-2.7%
Margem de Lucro Líquido
-3.1%
Sua barra de distintivos está vazia — fixe uma métrica em qualquer lugar desta página.
ANIK Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$19.10
Capitalização de Mercado (MRQ)
$256M
P/E (TTM)
-70.7
EPS (TTM)
$-0.27
Receita (TTM)
$121M
ROE (TTM)
-2.7%
Intervalo 52 Semanas
$9–$23
ANIK Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
intervalo
barras
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita$113M2016-12-31 → 2025-12-31
EPS$-0.762016-12-31 → 2025-12-31
Fluxo de caixa livre$4M2016-12-31 → 2025-12-31
Margem líquida-3.1%2016-12-31 → 2025-12-31
Avaliação e Proporções
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | ANIK | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | -70.7média 5A ≈15.6 | ≈15.6 | · | · | |
| P/S (TTM) | 2.1média 5A ≈2.6 | ≈2.6 | 30.3 | Subvalorizado | |
| P/B (MRQ) | 1.9média 5A ≈1.4 | ≈1.4 | 2.1 | Subvalorizado | |
| Preço / FCF (TTM) | 454.8média 5A ≈-13.2 | ≈-13.2 | · | · | |
| Preço / Fluxo de Caixa (TTM) | 42.8média 5A ≈53.9 | ≈53.9 | · | · | |
| Preço / Valor Patrimonial Tangível (MRQ) | 1.9média 5A ≈1.8 | ≈1.8 | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | ANIK | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Bruta (TTM) | 62.2%média 5A ≈59.0% | ≈59.0% | · | · | |
| Margem Operacional (TTM) | -4.2%média 5A ≈-6.2% | ≈-6.2% | -587.5% | Primeira linha | |
| EBITDA Margin (Margem EBITDA) | -9.8%média 5A ≈-6.2% | ≈-6.2% | -587.5% | Primeira linha | |
| Margem de Impostos Pré-Tributação (TTM) | -2.4%média 5A ≈-5.2% | ≈-5.2% | -1.3% | Primeira linha | |
| Margem de Lucro Líquido (TTM) | -3.1%média 5A ≈-15.8% | ≈-15.8% | -631.4% | Primeira linha | |
| ROA (TTM) | -2.0%média 5A ≈-8.1% | ≈-8.1% | -37.6% | Primeira linha | |
| ROE (TTM) | -2.7%média 5A ≈-11.3% | ≈-11.3% | -41.7% | Primeira linha | |
| ROIC | -8.3%média 5A ≈-5.7% | ≈-5.7% | -8.3% | Em linha |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | ANIK | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Índice de liquidez corrente (MRQ) | 4.5média 5A ≈5.3 | ≈5.3 | 7.7 | Baixa liquidez | |
| Quick Ratio (Índice de Liquidez Seca) | 4.8média 5A ≈4.7 | ≈4.7 | 5.1 | Baixa liquidez |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | ANIK | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | -5.9%média 5A ≈-2.0% | ≈-2.0% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | -0.30%média 5A ≈-3.2% | ≈-3.2% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | -2.9% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | ANIK | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 0.6média 5A ≈0.5 | ≈0.5 | 0.2 | Primeira linha | |
| Inventory Turnover (Giro de Estoque) | 2.3média 5A ≈1.8 | ≈1.8 | · | · | |
| Receivables Turnover (Giro de Contas a Receber) | 4.8média 5A ≈4.9 | ≈4.9 | 3.9 | Primeira linha | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$480.1K | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
148.4%
Próximo relatório
Nov 03, 2026
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Jul 28, 2026 | $0.42 | $-0.08 | 614.7% |
| 31 de Março de 2026 | Mai 7, 2026 | $0.27 | $-0.16 | 265.4% |
| 31 de Dezembro de 2025 | $0.02 | $-0.22 | 109.1% | |
| 30 de Setembro de 2025 | $-0.16 | $-0.28 | 41.9% | |
| 30 de Junho de 2025 | $-0.28 | $-0.26 | -8.4% | |
| 31 de Março de 2025 | $-0.34 | $-0.15 | -132.6% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $113M | $120M | $121M | $114M | $148M | $130M | $115M | $106M | $113M | $103M | $93M | $106M | |
| Cost of Revenue | $49M | $44M | $38M | $41M | $65M | $61M | $29M | $31M | $27M | $24M | $21M | $21M | |
| Gross Profit | $64M | $76M | $83M | $73M | $83M | $69M | $86M | $74M | · | · | · | · | |
| R&D Expense | $26M | $26M | $22M | $18M | $27M | $23M | $17M | $18M | $19M | $11M | $9M | $8M | |
| SG&A Expense | $49M | $56M | $60M | $51M | $74M | $60M | $35M | $34M | $22M | $18M | $15M | $15M | |
| Operating Expenses | $75M | $81M | $82M | $70M | $80M | $97M | $52M | $53M | $68M | $53M | $45M | $44M | |
| Operating Income | $-11M | $-5M | $844.0K | $4M | $3M | $-28M | $34M | $22M | $46M | $51M | $48M | $61M | |
| Pretax Income | $-9M | $-3M | $3M | $4M | $2M | $-29M | $36M | $23M | $46M | $51M | $48M | $62M | |
| Income Tax | $672.0K | $6M | $7M | $2M | $-2M | $-5M | $9M | $4M | $14M | $18M | $17M | $23M | |
| Net Income | $-11M | $-56M | $-83M | $-15M | $4M | $-24M | $27M | $19M | $32M | $33M | $31M | $38M | |
| EPS (Basic) | $-0.76 | $-3.83 | $-5.64 | $-1.02 | $0.29 | $-1.69 | $1.93 | $1.30 | $2.18 | $2.22 | $2.06 | $2.61 | |
| EPS (Diluted) | $-0.76 | $-3.83 | $-5.64 | $-1.02 | $0.28 | $-1.69 | $1.89 | $1.27 | $2.11 | $2.15 | $2.01 | $2.51 | |
| Shares (Basic) | 14,339,000 | 14,721,000 | 14,656,000 | 14,561,000 | 14,401,000 | 14,222,000 | 14,121,000 | 14,442,000 | 14,575,000 | 14,682,000 | 14,934,000 | 14,678,000 | |
| Shares (Diluted) | 14,339,000 | 14,721,000 | 14,656,000 | 14,787,000 | 14,634,000 | 14,222,000 | 14,374,000 | 14,689,000 | 15,068,000 | 15,116,000 | 15,321,000 | 15,269,000 | |
| EBITDA | $-11M | $-5M | · | $-19M | $3M | $-28M | $34M | $22M | $46M | $51M | $48M | $61M |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $57M | $56M | $69M | $86M | $94M | $96M | $157M | $89M | $133M | $104M | $111M | $100M | |
| Short-term Investments | $24M | $24M | $26M | $35M | $30M | $3M | $27M | $70M | $24M | $20M | $28M | $7M | |
| Receivables | $24M | $24M | $26M | $35M | $30M | $24M | $23M | $21M | $24M | $28M | $22M | $17M | |
| Inventory | $19M | $24M | $24M | $40M | $36M | $46M | $22M | $21M | $22M | $16M | $15M | $12M | |
| Prepaid Expense | $3M | $5M | $7M | $9M | $8M | $9M | $4M | $2M | $3M | $2M | $1M | $1M | |
| Current Assets | $103M | $114M | $163M | $170M | $169M | $177M | $234M | $203M | $206M | $170M | $176M | $138M | |
| PP&E (Net) | $40M | $39M | $37M | $48M | $48M | $51M | $51M | $54M | $56M | $52M | $40M | $32M | |
| PP&E (Gross) | $92M | $85M | $81M | $94M | $87M | $85M | $79M | $78M | $76M | $79M | $65M | $54M | |
| Accum. Depreciation | $51M | $46M | $44M | $46M | $40M | $35M | $29M | $24M | $20M | $27M | $25M | $22M | |
| Goodwill | $8M | $7M | $8M | $7M | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $8M | |
| Intangibles | $2M | $2M | $3M | $75M | $82M | $91M | $8M | $9M | $11M | $10M | $12M | $15M | |
| Other Non-current Assets | $4M | $6M | $6M | $17M | $20M | $15M | $7M | $5M | $1M | $69.0K | · | · | |
| Total Assets | $190M | $203M | $271M | $349M | $348M | $366M | $331M | $279M | $283M | $240M | $236M | $193M | |
| Accounts Payable | $6M | $6M | $6M | $9M | $8M | $9M | $4M | $3M | $7M | $2M | $8M | $1M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | $6M | $6M | $6M | $5M | |
| Current Liabilities | $22M | $23M | $31M | $28M | $30M | $37M | $16M | $11M | $13M | $9M | $17M | $6M | |
| Capital Leases | $24M | $24M | $26M | $29M | $19M | $21M | $21M | · | · | · | · | · | |
| Deferred Tax | · | · | $0 | $6M | $10M | $12M | $4M | $4M | $5M | $7M | $7M | $8M | |
| Other Non-current Liabilities | $701.0K | $772.0K | $404.0K | $398.0K | $1M | $1M | $357.0K | $550.0K | $660.0K | $2M | $781.0K | $894.0K | |
| Common Stock | $139.0K | $144.0K | $147.0K | $146.0K | $144.0K | $143.0K | $143.0K | $142.0K | $147.0K | $146.0K | $150.0K | $149.0K | |
| Retained Earnings | $61M | $72M | $128M | $211M | $226M | $221M | $245M | $218M | $200M | $168M | $136M | $105M | |
| AOCI | $-5M | $-7M | $-6M | $-6M | $-6M | $-5M | $-6M | $-6M | $-5M | $-7M | $-7M | $-4M | |
| Stockholders' Equity | $143M | $154M | $212M | $286M | $287M | $272M | $288M | $264M | $263M | $223M | $211M | $178M | |
| Liabilities + Equity | $190M | $203M | $271M | $349M | $348M | $366M | $331M | $279M | $283M | $240M | $236M | $193M | |
| Shares Outstanding | 13,889,000 | 14,416,000 | 14,660,000 | 14,625,000 | 14,441,000 | 14,329,000 | 14,308,000 | 14,210,000 | 14,688,000 | 14,627,000 | 15,037,000 | 14,851,703 |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $7M | $6M | $7M | $6M | $6M | $5M | $6M | $4M | $4M | $4M | $5M | |
| Stock-based Comp | $10M | $13M | $15M | $14M | $11M | $5M | $6M | $11M | $6M | $3M | $2M | $2M | |
| Deferred Tax | $-7.0K | $260.0K | $-6M | $-5M | $-2M | $-4M | $794.0K | $-2M | $-1M | $-65.0K | $-747.0K | $815.0K | |
| Amort. of Intangibles | $400.0K | $700.0K | $600.0K | $600.0K | $8M | $7M | $1M | $1M | $1M | $1M | $1M | $2M | |
| Operating Cash Flow | $11M | $5M | $-2M | $4M | $8M | $13M | $37M | $35M | $41M | $24M | $40M | $40M | |
| CapEx | $7M | $8M | $5M | $7M | $5M | $2M | $3M | $5M | $9M | $14M | $9M | $2M | |
| Investing Cash Flow | $-401.0K | $-8M | $-5M | $-7M | $-3M | $-71M | $40M | $-50M | $-12M | $-7M | $-30M | $-8M | |
| Debt Issued | · | · | · | $0 | $0 | $50M | $0 | $0 | · | · | · | · | |
| Net Debt Issued | · | · | · | $0 | $0 | $-350.0K | · | · | · | · | · | · | |
| Stock Repurchased | $9M | $11M | $5M | $0 | $0 | $0 | $30M | $30M | · | $25M | · | · | |
| Net Stock Activity | $-9M | $-11M | · | · | $0 | $0 | $-30M | $-30M | · | $-25M | · | · | |
| Financing Cash Flow | $-11M | $-13M | $-6M | $-5M | $-7M | $-4M | $-8M | $-29M | $314.0K | $-24M | $1M | $5M | |
| Net Change in Cash | $322.0K | $-16M | $-13M | $-8M | $-1M | $-62M | $68M | $-44M | $29M | $-6M | $11M | $37M | |
| Taxes Paid | $1M | $4M | $3M | $106.0K | $1M | $993.0K | $9M | · | · | · | · | · | |
| Free Cash Flow | $4M | $-2M | · | $-3M | $3M | $11M | $34M | $30M | $32M | $10M | $30M | $38M |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 56.6% | 63.4% | · | 59.9% | 56.1% | 52.9% | · | · | · | · | · | · | |
| Operating Margin | -9.8% | -4.2% | · | -12.4% | 1.8% | -21.7% | 29.9% | 20.6% | 40.3% | 48.9% | 51.8% | 58.2% | |
| Net Margin | -9.6% | -47.0% | · | -9.5% | 2.8% | -18.4% | 23.7% | 17.7% | 28.1% | 31.5% | 33.1% | 36.3% | |
| Pretax Margin | -8.2% | -2.3% | · | -12.0% | 1.6% | -21.9% | 31.5% | 22.0% | 40.7% | 49.2% | 51.9% | 58.2% | |
| EBITDA Margin | -9.8% | -4.2% | · | -12.4% | 1.8% | -21.7% | 29.9% | 20.6% | 40.3% | 48.9% | 51.8% | 58.2% | |
| ROA | -5.5% | -23.8% | · | -4.3% | 1.2% | -6.9% | 8.9% | 6.7% | 12.2% | 13.7% | 14.3% | 21.9% | |
| ROE | -7.5% | -33.8% | · | -5.2% | 1.4% | -8.6% | 9.5% | 7.2% | 13.1% | 15.0% | 15.8% | 24.4% | |
| ROIC | -8.3% | -10.6% | · | -5.4% | 1.6% | -8.7% | 8.9% | 6.7% | 11.9% | 14.5% | 14.5% | 21.5% |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 4.9 | · | 6.1 | 5.7 | 4.8 | 14.4 | 18.0 | 15.8 | 19.4 | 10.2 | 23.3 | |
| Quick Ratio | 4.8 | 4.4 | · | 5.6 | 4.2 | 3.3 | 12.8 | 15.9 | 13.9 | 17.3 | 9.3 | 20.8 |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.5 | · | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.6 | |
| Inventory Turnover | 2.3 | 1.8 | · | 1.7 | 1.6 | 1.4 | 1.3 | 1.4 | 1.4 | 1.6 | 1.5 | 1.8 | |
| Receivables Turnover | 4.8 | 4.8 | · | 4.4 | 5.5 | 5.5 | 5.2 | 4.7 | 4.4 | 4.2 | 4.8 | 5.9 |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $10.33 | $10.68 | · | $19.53 | $19.88 | $19.01 | $20.16 | $18.55 | $17.94 | $15.23 | $14.02 | $11.99 | |
| Revenue / Share | $7.87 | $8.15 | · | $10.73 | $10.10 | $9.17 | $7.97 | $7.19 | $7.53 | $6.84 | $6.07 | $6.92 | |
| Cash Flow / Share | $0.78 | $0.37 | · | $0.30 | $0.57 | $0.92 | $2.57 | $2.38 | $2.71 | $1.57 | $2.55 | $2.62 | |
| Cash / Share | $4.14 | $3.86 | · | $5.90 | $6.54 | $6.69 | $11.01 | $6.27 | $9.07 | $7.13 | $7.36 | $6.74 | |
| EPS (TTM) | $-0.76 | $-3.83 | $-5.64 | $-1.02 | $0.28 | $-1.69 | $1.89 | $1.27 | $2.11 | $2.15 | $2.01 | $2.51 |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -5.9% | -0.73% | 6.1% | -23.0% | 13.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -0.30% | -6.7% | -2.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -2.9% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $113M | $120M | $121M | $114M | $148M | $130M | $115M | $106M | $113M | $103M | $93M | $106M | |
| Net Income TTM | $-11M | $-56M | $-83M | $-15M | $4M | $-24M | $27M | $19M | $32M | $33M | $31M | $38M | |
| Market Cap | $133M | $237M | · | $433M | $517M | $649M | $742M | $478M | $792M | $716M | $574M | $605M | |
| P/E | -12.6 | -4.3 | -4.0 | -29.0 | 128.0 | -26.8 | 27.4 | 26.5 | 25.5 | 22.8 | 19.0 | 16.2 | |
| P/S | 1.2 | 2.0 | · | 3.8 | 3.5 | 5.0 | 6.5 | 4.5 | 7.0 | 6.9 | 6.2 | 5.7 | |
| P/B | 0.9 | 1.5 | · | 1.5 | 1.8 | 2.4 | 2.6 | 1.8 | 3.0 | 3.2 | 2.7 | 3.4 | |
| P / Tangible Book | 1.0 | 1.6 | 1.6 | 2.1 | 2.6 | 3.8 | · | · | · | · | · | · | |
| P / Cash Flow | 11.9 | 43.9 | · | 98.2 | 61.6 | 49.6 | 20.0 | 13.7 | 19.4 | 30.1 | 14.7 | 15.1 | |
| P / FCF | 30.6 | -101.8 | · | -140.7 | 159.0 | 56.7 | 21.7 | 15.8 | 24.9 | 73.2 | 19.2 | 15.7 | |
| Earnings Yield | -7.9% | -23.3% | -24.9% | -3.5% | 0.78% | -3.7% | 3.6% | 3.8% | 3.9% | 4.4% | 5.3% | 6.2% |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $33M | $30M | $31M | $28M | $28M | $26M | $31M | $30M | $31M | $29M | $-3M | $41M | $44M | $38M | $-3M | $40M | |
| Cost of Revenue | $11M | $11M | $11M | $12M | $14M | $11M | $13M | $10M | $10M | $10M | $-9M | $17M | $15M | $15M | $-7M | $17M | |
| Gross Profit | $21M | $19M | $19M | $16M | $14M | $15M | $17M | $19M | $20M | $19M | $6M | $25M | $29M | $23M | $4M | $23M | |
| R&D Expense | $7M | $7M | $6M | $7M | $6M | $6M | $7M | $6M | $7M | $6M | $-3M | $8M | $9M | $8M | $-2M | $7M | |
| SG&A Expense | $11M | $18M | $12M | $12M | $12M | $13M | $11M | $14M | $16M | $15M | $-16M | $25M | $24M | $27M | $-11M | $21M | |
| Operating Expenses | $18M | $24M | $19M | $19M | $19M | $19M | $18M | $19M | $22M | $21M | $-19M | $33M | $33M | $35M | $-13M | $29M | |
| Operating Income | $3M | $-5M | $646.0K | $-3M | $-4M | $-4M | $-705.0K | $-81.0K | $-2M | $-3M | $25M | $-8M | $-4M | $-13M | $16M | $-6M | |
| Pretax Income | $3M | $-5M | $764.0K | $-2M | $-4M | $-4M | $39.0K | $325.0K | $-1M | $-2M | $25M | $-7M | $-3M | $-12M | $17M | $-5M | |
| Income Tax | $71.0K | $235.0K | $-1M | $939.0K | $681.0K | $89.0K | $3M | $2M | $1M | $43.0K | $9M | $-463.0K | $-329.0K | $-2M | $5M | $-1M | |
| Net Income | $3M | $-5M | $292.0K | $-2M | $-4M | $-5M | $-22M | $-30M | $-88.0K | $-5M | $-63M | $-7M | $-3M | $-10M | $-5M | $-4M | |
| EPS (Basic) | $0.25 | $-0.37 | $0.02 | $-0.16 | $-0.28 | $-0.34 | $-1.48 | $-2.03 | $-0.01 | $-0.31 | $-4.29 | $-0.45 | $-0.19 | $-0.71 | $-0.33 | $-0.29 | |
| EPS (Diluted) | $0.24 | $-0.37 | $0.02 | $-0.16 | $-0.28 | $-0.34 | $-1.49 | $-2.03 | $0.00 | $-0.31 | $-4.29 | $-0.45 | $-0.19 | $-0.71 | $-0.33 | $-0.29 | |
| Shares (Basic) | 13,330,000 | 13,531,000 | · | 14,419,000 | 14,364,000 | 14,297,000 | · | 14,768,000 | 14,839,000 | 14,698,000 | · | 14,635,000 | 14,688,000 | 14,653,000 | · | 14,603,000 | |
| Shares (Diluted) | 13,717,000 | 13,531,000 | · | 14,419,000 | 14,517,000 | 14,297,000 | · | 14,768,000 | 14,856,000 | 14,698,000 | · | 14,635,000 | 14,688,000 | 14,653,000 | · | 14,603,000 | |
| EBITDA | $3M | $-5M | · | $-3M | $-4M | $-4M | · | $-28M | $161.0K | $-5M | · | $-8M | $-4M | $-13M | · | $-6M |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $38M | $41M | $57M | $58M | $53M | $53M | $56M | $62M | $63M | $69M | · | $71M | $65M | $80M | · | $88M | |
| Short-term Investments | · | $26M | $24M | $22M | $24M | $22M | $24M | $28M | $34M | $32M | · | $35M | $37M | $31M | · | $34M | |
| Receivables | $29M | $26M | $24M | $22M | $24M | $22M | $24M | $28M | $34M | $32M | · | $35M | $37M | $31M | · | · | |
| Inventory | $29M | $23M | $19M | $16M | $17M | $21M | $24M | $40M | $51M | $49M | · | $44M | $43M | $41M | · | $37M | |
| Prepaid Expense | $3M | $4M | $3M | $5M | $5M | $6M | $5M | $6M | $7M | $9M | · | $8M | $8M | $9M | · | $9M | |
| Current Assets | $99M | $94M | $103M | $102M | $99M | $103M | $114M | $136M | $155M | $159M | · | $157M | $152M | $160M | · | $168M | |
| PP&E (Net) | $40M | $40M | $40M | $41M | $41M | $40M | $39M | $45M | $48M | $46M | · | $46M | $48M | $49M | · | $47M | |
| PP&E (Gross) | $94M | $92M | $92M | · | $90M | $88M | $85M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $54M | $53M | $51M | · | $49M | $48M | $46M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $8M | $7M | $7M | $8M | $7M | $7M | $7M | $7M | $7M | |
| Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $4M | $4M | · | $69M | $71M | $73M | · | $77M | |
| Other Non-current Assets | $3M | $4M | $4M | $6M | $6M | $6M | $6M | $11M | $20M | $18M | · | $19M | $19M | $18M | · | $18M | |
| Total Assets | $183M | $179M | $190M | $189M | $188M | $191M | $203M | $231M | $263M | $264M | · | $328M | $329M | $339M | · | $348M | |
| Accounts Payable | $6M | $6M | $6M | $5M | $5M | $5M | $6M | $7M | $10M | $10M | · | $8M | $8M | $9M | · | $8M | |
| Current Liabilities | $22M | $21M | $22M | $19M | $16M | $18M | $23M | $25M | $26M | $28M | · | $28M | $23M | $29M | · | $26M | |
| Capital Leases | $23M | $24M | $24M | $23M | $23M | $24M | $24M | $25M | $26M | $26M | · | $27M | $28M | $28M | · | $29M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $2M | $3M | $4M | · | $7M | |
| Other Non-current Liabilities | $730.0K | $726.0K | $701.0K | $761.0K | $756.0K | $744.0K | $772.0K | $806.0K | $407.0K | $404.0K | · | $400.0K | $401.0K | $399.0K | · | $474.0K | |
| Common Stock | $134.0K | $133.0K | $139.0K | $144.0K | $144.0K | $143.0K | $144.0K | $147.0K | $148.0K | $148.0K | · | $146.0K | $147.0K | $147.0K | · | $146.0K | |
| Retained Earnings | $59M | $56M | $61M | $60M | $63M | $67M | $72M | $94M | $123M | $124M | · | $191M | $198M | $200M | · | $216M | |
| AOCI | $-5M | $-5M | $-5M | $-5M | $-5M | $-6M | $-7M | $-6M | $-6M | $-6M | · | $-7M | $-6M | $-6M | · | $-7M | |
| Stockholders' Equity | $137M | $134M | $143M | $147M | $148M | $148M | $154M | $180M | $210M | $209M | $212M | $270M | $274M | $278M | $286M | $285M | |
| Liabilities + Equity | $183M | $179M | $190M | $189M | $188M | $191M | $203M | $231M | $263M | $264M | · | $328M | $329M | $339M | · | $348M | |
| Shares Outstanding | 13,383,000 | 13,357,000 | 13,889,000 | 14,421,000 | 14,418,000 | 14,336,000 | 14,416,000 | 14,694,000 | 14,839,000 | 14,821,000 | · | 14,637,000 | 14,657,000 | 14,741,000 | · | 14,607,000 |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $2M | $7M | $2M | $2M | $3M | $3M | $2M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Deferred Tax | $129.0K | $108.0K | $-25.0K | $3.0K | $-3.0K | $18.0K | $234.0K | $-184.0K | $17.0K | $193.0K | $-2M | $-1M | $-904.0K | $-2M | $-2M | $-1M | |
| Amort. of Intangibles | · | · | $0 | $0 | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $100.0K | $-5M | $2M | $2M | $2M | $-5M | $2M | |
| Restructuring | $519.0K | $2M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-684.0K | $-5M | $5M | $7M | $-189.0K | $-130.0K | $2M | $5M | $-1M | $-126.0K | $4M | $6M | $-8M | $-4M | $481.0K | $3M | |
| CapEx | $1M | $1M | $648.0K | $2M | $1M | $3M | $1M | $1M | $3M | $2M | $2M | $741.0K | $1M | $1M | $3M | $2M | |
| Investing Cash Flow | $-1M | $-1M | $198.0K | $-2M | $-539.0K | $2M | $-1M | $-2M | $-3M | $-2M | $-2M | $-741.0K | $-1M | $-1M | $-3M | $-2M | |
| Stock Repurchased | $853.0K | $9M | $6M | $0 | $0 | $4M | $6M | $4M | $1M | $0 | $0 | $0 | · | · | $0 | $0 | |
| Net Stock Activity | · | $-9M | · | · | · | $-4M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-701.0K | $-10M | $-5M | $-13.0K | $179.0K | $-5M | $-5M | $-4M | $-1M | $-2M | $342.0K | $-110.0K | $-5M | $-2M | $667.0K | $-5M | |
| Net Change in Cash | $-3M | $-16M | $-509.0K | $5M | $-204.0K | $-4M | $-5M | $-454.0K | $-6M | $-4M | $2M | $6M | $-15M | $-7M | $-1M | $-4M | |
| Free Cash Flow | · | $-6M | · | · | · | $-3M | · | · | · | $-2M | · | · | · | $-5M | · | · |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 65.1% | 64.1% | · | 56.0% | 50.9% | 56.1% | · | 3.7% | 65.3% | 60.8% | · | 60.2% | 65.4% | 60.2% | · | 56.6% | |
| Operating Margin | 9.1% | -18.5% | · | -11.6% | -14.8% | -16.4% | · | -72.3% | 0.38% | -12.5% | · | -18.5% | -8.2% | -33.1% | · | -14.4% | |
| Net Margin | 10.2% | -17.1% | · | -8.4% | -14.1% | -18.6% | · | -77.2% | -0.21% | -11.1% | · | -15.9% | -6.2% | -27.3% | · | -10.4% | |
| Pretax Margin | 10.4% | -16.3% | · | -8.0% | -14.1% | -14.8% | · | -71.2% | 1.8% | -11.0% | · | -17.0% | -6.9% | -31.7% | · | -13.3% | |
| EBITDA Margin | 9.1% | -18.5% | · | -11.6% | -14.8% | -16.4% | · | -72.3% | 0.38% | -12.5% | · | -18.5% | -8.2% | -33.1% | · | -14.4% | |
| ROA | 1.8% | -2.7% | · | -1.1% | -1.8% | -2.1% | · | -10.7% | -0.03% | -1.5% | · | -1.9% | -0.80% | -3.0% | · | -1.2% | |
| ROE | 2.3% | -3.6% | · | -1.4% | -2.2% | -2.7% | · | -13.3% | -0.04% | -1.9% | · | -2.4% | -0.98% | -3.7% | · | -1.5% | |
| ROIC | 2.1% | -4.3% | · | -3.1% | -3.3% | -2.9% | · | -16.9% | -0.01% | -2.5% | · | -2.6% | -1.2% | -3.9% | · | -1.6% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 4.5 | · | 5.3 | 6.2 | 5.7 | · | 5.3 | 5.9 | 5.6 | · | 5.6 | 6.5 | 5.6 | · | 6.4 | |
| Quick Ratio | 3.0 | 4.4 | · | 5.4 | 6.3 | 5.4 | · | 4.7 | 5.0 | 4.7 | · | 5.0 | 5.9 | 4.9 | · | 4.6 |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.4 | 0.4 | 0.3 | · | 0.9 | 0.3 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.1 | 1.0 | 1.0 | · | 1.2 | 1.2 | 1.3 | · | 1.2 | 1.3 | 1.3 | · | · |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $10.26 | $10.02 | · | $10.18 | $10.24 | $10.35 | · | $12.24 | $14.17 | $14.07 | · | $18.48 | $18.70 | $18.83 | · | $19.51 | |
| Revenue / Share | $2.38 | $2.19 | · | $1.93 | $1.94 | $1.83 | · | $2.62 | $2.83 | $2.76 | · | $2.83 | $3.02 | $2.59 | · | $2.76 | |
| Cash Flow / Share | · | $-0.36 | · | · | · | $-0.01 | · | · | · | $-0.01 | · | · | · | $-0.25 | · | · | |
| Cash / Share | $2.87 | $3.07 | · | $4.02 | $3.69 | $3.72 | · | $4.24 | $4.23 | $4.63 | · | $4.83 | $4.44 | $5.41 | · | $6.01 | |
| EPS (TTM) | $-0.27 | $-0.79 | · | $-2.27 | $-4.14 | $-3.86 | · | $-6.63 | $-5.05 | $-5.24 | · | $-1.68 | $-1.52 | $-1.53 | · | $-1.10 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $121M | $116M | · | $113M | $115M | $117M | · | $86M | $98M | $112M | · | $121M | $120M | $115M | · | $152M | |
| Net Income TTM | $-4M | $-11M | · | $-33M | $-61M | $-57M | · | $-98M | $-74M | $-77M | · | $-25M | $-22M | $-22M | · | $-16M | |
| Market Cap | $196M | $194M | · | $136M | $153M | $215M | · | $363M | $376M | $376M | · | $273M | $381M | $423M | · | $348M | |
| P/E | -54.2 | -18.4 | · | -4.1 | -2.6 | -3.9 | · | -3.7 | -5.0 | -4.8 | · | -11.1 | -17.1 | -18.8 | · | -21.6 | |
| P/S | 1.6 | 1.7 | · | 1.2 | 1.3 | 1.8 | · | 4.2 | 3.8 | 3.4 | · | 2.3 | 3.2 | 3.7 | · | 2.3 | |
| P/B | 1.4 | 1.4 | · | 0.9 | 1.0 | 1.5 | · | 2.0 | 1.8 | 1.8 | · | 1.0 | 1.4 | 1.5 | · | 1.2 | |
| P / Tangible Book | 1.5 | 1.6 | · | 1.0 | 1.1 | 1.6 | · | 2.1 | 1.9 | 1.9 | · | 1.4 | 1.9 | 2.1 | · | 1.7 | |
| P / Cash Flow | · | -40.0 | · | · | · | -1657.5 | · | · | · | -2987.7 | · | · | · | -117.0 | · | · | |
| Earnings Yield | -1.8% | -5.5% | · | -24.1% | -39.1% | -25.7% | · | -26.8% | -19.9% | -20.6% | · | -9.0% | -5.9% | -5.3% | · | -4.6% |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $113M | $120M | $121M | $114M | $148M |
| Margem Bruta % | 56.6% | 63.4% | · | 59.9% | 56.1% |
| Margem Operacional % | -9.8% | -4.2% | · | -12.4% | 1.8% |
| Lucro líquido | $-11M | $-56M | $-83M | $-15M | $4M |
| EPS Diluído | $-0.76 | $-3.83 | $-5.64 | $-1.02 | $0.28 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 4.7 | 4.9 | · | 6.1 | 5.7 |
| Índice de Liquidez Seca | 4.8 | 4.4 | · | 5.6 | 4.2 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $4M | $-2M | · | $-3M | $3M |
Investidores institucionais (13F) 142 declarantes · $180.0M total · Em 30 de Setembro de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Detentores
142
Valor detido
$180.0M
Novas posições
20
Posições encerradas
12
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 20 (-6 vs trimestre anterior) | 12 (-4 vs trimestre anterior) | 46 (-3 vs trimestre anterior) | 40 (+3 vs trimestre anterior) | -63K |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| BlackRock, Inc. | $21.208.688 | 1.449.671 | 11,78% | Ações |
| Caligan Partners LP | $20.995.952 | 1.435.130 | 11,66% | Ações |
| MORGAN STANLEY | $8.987.502 | 614.320 | 4,99% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $8.370.013 | 572.113 | 4,65% | Ações |
| AQR CAPITAL MANAGEMENT LLC | $8.190.546 | 559.846 | 4,55% | Ações |
| BOOTHBAY FUND MANAGEMENT, LLC | $7.748.633 | 529.640 | 4,30% | Ações |
| VANGUARD GROUP INC | $7.487.776 | 779.165 | 4,16% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $7.043.131 | 481.417 | 3,91% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $6.599.818 | 451.095 | 3,67% | Ações |
| CAPITAL MANAGEMENT CORP /VA | $6.561.167 | 448.474 | 3,64% | Ações |
| DEUTSCHE BANK AG\ | $5.172.466 | 353.552 | 2,87% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $4.852.628 | 331.577 | 2,70% | Ações |
| STATE STREET CORP | $4.563.038 | 311.896 | 2,53% | Ações |
| TWO SIGMA INVESTMENTS, LP | $3.700.863 | 252.964 | 2,06% | Ações |
| D. E. Shaw & Co., Inc. | $3.585.316 | 245.066 | 1,99% | Ações |
| GOLDMAN SACHS GROUP INC | $3.477.873 | 237.722 | 1,93% | Ações |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3.182.464 | 217.530 | 1,77% | Ações |
| Nuveen, LLC | $2.290.151 | 156.538 | 1,27% | Ações |
| Quantinno Capital Management LP | $2.271.410 | 155.257 | 1,26% | Ações |
| UBS Group AG | $2.133.288 | 145.816 | 1,18% | Ações |
| Man Group plc | $2.058.617 | 140.712 | 1,14% | Ações |
| Hillsdale Investment Management Inc. | $2.030.951 | 138.821 | 1,13% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.658.662 | 113.374 | 0,92% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1.560.202 | 106.644 | 0,87% | Ações |
| AMERICAN CENTURY COMPANIES INC | $1.515.068 | 103.559 | 0,84% | Ações |
| NORTHERN TRUST CORP | $1.435.701 | 98.134 | 0,80% | Ações |
| ENVESTNET ASSET MANAGEMENT INC | $1.298.486 | 88.755 | 0,72% | Ações |
| GLOBEFLEX CAPITAL L P | $1.281.588 | 87.600 | 0,71% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $1.280.520 | 87.527 | 0,71% | Ações |
| JANE STREET GROUP, LLC | $1.247.310 | 85.257 | 0,69% | Ações |
| TWO SIGMA ADVISERS, LP | $1.215.502 | 126.483 | 0,68% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.123.189 | 76.773 | 0,62% | Ações |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $1.049.819 | 71.758 | 0,58% | Ações |
| Cove Street Capital, LLC | $958.386 | 101.956 | 0,53% | Ações |
| IRONWOOD INVESTMENT MANAGEMENT LLC | $958.309 | 65.503 | 0,53% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $935.632 | 63.953 | 0,52% | Ações |
| Assenagon Asset Management S.A. | $921.924 | 63.016 | 0,51% | Ações |
| JPMORGAN CHASE & CO | $813.768 | 54.215 | 0,45% | Ações |
| DIKER MANAGEMENT LLC | $785.000 | 53.662 | 0,44% | Ações |
| FMR LLC | $775.095 | 52.980 | 0,43% | Ações |
| AMERIPRISE FINANCIAL INC | $765.953 | 52.355 | 0,43% | Ações |
| BARCLAYS PLC | $765.427 | 52.319 | 0,43% | Ações |
| HSBC HOLDINGS PLC | $727.024 | 50.105 | 0,40% | Ações |
| Indivisible Partners | $676.696 | 46.254 | 0,38% | Ações |
| Advyzon Investment Management, LLC | $667.450 | 45.622 | 0,37% | Ações |
| Cerity Partners LLC | $594.885 | 40.662 | 0,33% | Ações |
| Palumbo Wealth Management LLC | $586.312 | 40.076 | 0,33% | Ações |
| Bank of New York Mellon Corp | $567.252 | 38.773 | 0,32% | Ações |
| Corient Private Wealth LP | $518.123 | 35.415 | 0,29% | Ações |
| STATE OF WISCONSIN INVESTMENT BOARD | $495.957 | 33.900 | 0,28% | Ações |
Ativistas e proprietários de 5%+ 3 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Caligan Partners LP, David Johnson ×6 declarações | 27 de Janeiro de 2026 | 9,95% | Emenda | · | SEC |
| ANDREW E. GOLD, RONIT GOLD | 15 de Novembro de 2004 | · | Declaração inicial | Investimento passivo | SEC |
| Pessoa de relato não divulgada | 22 de Abril de 2004 | · | Declaração inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Executivos da empresa 43 insiders · 20 diretores · 18 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Stephen D. Griffin | President and CEO | 3 de Junho de 2026 M | 45.973 | 1 | 0 | $149.938 |
| Joseph G Darling | President and CEO; Director | 27 de Julho de 2019 F | 20.289 | 0 | 0 | $0 |
| Charles H Sherwood | CEO and Director | 2 de Março de 2018 A | 189.891 | 0 | 0 | $0 |
| Michael L Levitz | EVP, CFO, Treasurer | 15 de Março de 2024 A | 46.955 | 0 | 0 | $0 |
| Sylvia Cheung | Chief Financial Officer | 25 de Fevereiro de 2020 A | 49.281 | 0 | 0 | $0 |
| Kevin W Quinlan | Chief Financial Officer | 27 de Março de 2013 S | 27.112 | 0 | 0 | $0 |
| Francesco J Luppino | Chief Operating Officer | 3 de Fevereiro de 2015 A | 5.979 | 0 | 0 | $0 |
| Ian Mcleod | SVP, CAO & Treasurer | 19 de Março de 2026 A | 24.107 | 0 | 0 | $0 |
| David Colleran | EVP, General Counsel, Corp Sec | 15 de Março de 2026 M | 67.570 | 0 | 0 | $0 |
| Anne Nunes | SVP, Chief Operations Officer | 17 de Março de 2025 M | 20.654 | 0 | 0 | $0 |
| Thomas Finnerty | EVP, Human Resources | 9 de Março de 2022 M | 24.598 | 0 | 0 | $0 |
| James Loerop | EVP Business Development | 8 de Julho de 2021 M | 5.592 | 0 | 0 | $0 |
| Richard Hague | Chief Commercial Officer | 27 de Fevereiro de 2019 A | 21.419 | 0 | 0 | $0 |
| Edward S. Ahn | Chief Tech & Strategy Officer | 27 de Fevereiro de 2019 A | 6.575 | 0 | 0 | $0 |
| Dana M. Alexander | Chief Operations Officer | 27 de Janeiro de 2017 A | · | 0 | 0 | $0 |
| Stephen R. Mascioli | Chief Medical Officer | 4 de Abril de 2016 A | · | 0 | 0 | $0 |
| Carol A Barnett | Chief Commercial Officer | 27 de Janeiro de 2014 A | 6.100 | 0 | 0 | $0 |
| John W Sheets JR | Chief Scientific Officer | 2 de Outubro de 2013 A | 10.000 | 0 | 0 | $0 |
| William Mrachek | Vice President, Human Resource | 18 de Janeiro de 2011 A | 6.854 | 0 | 0 | $0 |
| Constance H Garrison | VP Reg.,Clinical & Qlty. Sys. | 8 de Novembro de 2006 A | · | 0 | 0 | $0 |
| Stephen Richard | Conselheiro | 18 de Junho de 2026 A | 58.273 | 0 | 0 | $0 |
| Joseph H Capper | Conselheiro | 18 de Junho de 2026 A | 30.805 | 0 | 0 | $0 |
| Sheryl L Conley | Conselheiro | 18 de Junho de 2026 A | 52.970 | 0 | 0 | $0 |
| John B Henneman III | Conselheiro | 18 de Junho de 2026 A | 65.273 | 1 | 0 | $73.300 |
| Cheryl R Blanchard | Conselheiro | 15 de Março de 2026 M | 258.788 | 0 | 0 | $0 |
| Glenn R. Larsen | Conselheiro | 20 de Junho de 2025 A | 50.258 | 0 | 0 | $0 |
| Susan L N Vogt | Conselheiro | 20 de Junho de 2025 A | 50.213 | 0 | 0 | $0 |
| William R Jellison | Conselheiro | 20 de Junho de 2025 A | 20.403 | 0 | 0 | $0 |
| Jeffery S Thompson | Conselheiro | 14 de Junho de 2023 A | 31.575 | 0 | 0 | $0 |
| Raymond J Land | Conselheiro | 16 de Junho de 2021 A | 12.125 | 0 | 0 | $0 |
| Joseph I Bower | Conselheiro | 25 de Fevereiro de 2020 A | 17.117 | 0 | 0 | $0 |
| Steve E Wheeler | Conselheiro | 24 de Janeiro de 2018 A | 34.594 | 0 | 0 | $0 |
| John C Moran | Conselheiro | 7 de Agosto de 2015 S | 14.803 | 0 | 0 | $0 |
| Eugene A Davidson | Conselheiro | 18 de Janeiro de 2011 A | 71.763 | 0 | 0 | $0 |
| Harvey S Sadow | Conselheiro | 8 de Setembro de 2006 M | 10.000 | 0 | 0 | $0 |
| Fidia Farmaceutici S.p.A. | Detentor de 10% | 6 de Agosto de 2013 S | 711.192 | 0 | 0 | $0 |
| Gary P Fischetti | · | 4 de Agosto de 2026 P | 54.015 | 2 | 0 | $41.060 |
| Carol A Toth | · | 26 de Janeiro de 2006 A | · | 0 | 0 | $0 |
| Samuel F Mckay | · | 24 de Janeiro de 2006 A | 0 | 0 | 0 | $0 |
| Peter Litman | · | 3 de Outubro de 2005 A | · | 0 | 0 | $0 |
| James E Oneill | · | 10 de Fevereiro de 2005 A | · | 0 | 0 | $0 |
| Elizabeth Chen | · | 4 de Outubro de 2004 A | · | 0 | 0 | $0 |
| William J Knight | · | 27 de Setembro de 2004 M | 47.500 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 24 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,48% | 5.719 SH | 2 de Outubro de 2026 | Diário |
| IWC · iShares Trust | 0,06% | 38.986 SH | 11 de Setembro de 2026 | Diário |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,02% | 5.502 NS | 31 de Julho de 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,01% | 56.771 NS | 31 de Julho de 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 15.157 SH | 2 de Outubro de 2026 | Diário |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 65.730 SH | 19 de Agosto de 2026 | Diário |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 9.977 SH | 19 de Agosto de 2026 | Diário |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 1.336 SH | 2 de Outubro de 2026 | Diário |
| PKW · Invesco Exchange-Traded Fund Trust | 0,01% | 7.881 SH | 2 de Outubro de 2026 | Diário |
| IWM · iShares Trust | 0,01% | 305.635 SH | 11 de Setembro de 2026 | Diário |
| DFAS · Dimensional ETF Trust | 0,01% | 41.182 NS | 31 de Julho de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 800 NS | 31 de Julho de 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,00% | 7.426 NS | 31 de Julho de 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,00% | 6.027 NS | 31 de Julho de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 1.000 NS | 31 de Julho de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 6.180 SH | 4 de Setembro de 2026 | Diário |
| DCOR · Dimensional ETF Trust | 0,00% | 733 NS | 31 de Julho de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 1.436 NS | 31 de Julho de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 1.888 NS | 31 de Julho de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 162.458 SH | 19 de Agosto de 2026 | Diário |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 397.824 SH | 19 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.066 SH | 19 de Agosto de 2026 | Diário |
| DFAC · Dimensional ETF Trust | 0,00% | 900 NS | 31 de Julho de 2026 | N-PORT |
| IWN · iShares Trust | · | 104.276 SH | 11 de Setembro de 2026 | Diário |
ANIK Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
classificação · 8 analistas
COMPRA
Alvo mediano
$22.00
+15,2%
3 37,5%
Compra forte
4 50,0%
Compra
1 12,5%
Manter
0 0,0%
Venda
0 0,0%
Venda forte
Preço-alvo de 12 meses
2 analistas · 2026-09-29Alvo médio $22.00 +15,2%
← Abaixo de todos os alvos
Preço atual $19.10
Mín$21.00
Média$22.00
Máx$23.00
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| ANIK | $133M | -12.6 | -5.9% | -9.6% | -7.5% | 56.6% |
| STRO | $99M | -0.5 | 65.2% | -186.5% | 232.2% | · |
| GLSI | $300M | -14.7 | · | · | -2159.7% | · |
| IMRX | · | -5.2 | · | · | -45.3% | · |
| TLSI | · | · | · | · | · | · |
| EVMN | $540M | -1.5 | 85.7% | -529.8% | -401.2% | · |
| QTTB | $43M | 1.4 | · | 55.5% | 200.3% | · |
| PALI | $375M | -7.8 | · | · | -25.4% | · |
| CAMP | $318M | -2.3 | 436.5% | -2298.5% | -183.4% | · |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Fonte: SEC 10-Q arquivado Jul 29, 2026